National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Nanodevices
< Back to Main
    Posted: 01/28/2005
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 21  :  Dendrimers <  >  

Research is being done on a number of nanoparticles created to facilitate drug delivery. One such molecule with potential to link treatment with detection and diagnosis is known as a dendrimer. Dendrimers are man-made molecules about the size of an average protein, and have a branching shape. This shape gives them vast amounts of surface area to which scientists can attach therapeutic agents or other biologically active molecules. Researchers aim eventually to create nanodevices that do much more than deliver treatment.

Dendrimers

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov